PMID- 33775595 OWN - NLM STAT- MEDLINE DCOM- 20220404 LR - 20220531 IS - 1715-3360 (Electronic) IS - 0008-4182 (Linking) VI - 57 IP - 2 DP - 2022 Apr TI - Ocular manifestations of disseminated Mycobacterium chimaera infection after cardiothoracic surgery. PG - 90-97 LID - S0008-4182(21)00081-8 [pii] LID - 10.1016/j.jcjo.2021.02.032 [doi] AB - OBJECTIVE: To describe the ocular manifestations of disseminated Mycobacterium chimaera infection after cardiothoracic surgery. DESIGN: Retrospective, observational case series. PARTICIPANTS: Patients with disseminated M. chimaera infection treated at the University of Alberta Hospital and Royal Alexandra Hospital in Edmonton, Alberta, Canada. METHODS: Seven patients (14 eyes) with systemic M. chimaera infection after aortic graft and/or valvular surgeries were reviewed for ocular involvement. Cases were identified based on histopathologic analysis of cardiac tissue, repeat positive mycobacterial blood cultures, and cerebrospinal fluid analysis. Clinical ocular findings, fundus autofluorescence, fluorescein angiography, spectral-domain optical coherence tomography (SD-OCT), and autopsy results are described. RESULTS: The mean age of our patients was 63 years (range, 22-76 years). Aortic graft and/or valvular surgeries were performed between June 2015 and April 2016. The mean duration from surgery to diagnosis of infection was 27 months (range, 19-36 months). All patients exhibited white-yellowish choroidal lesions. Bilateral, multifocal choroiditis was observed in 6 patients (12 eyes), who died of disseminated M. chimaera infection despite aggressive, multiagent antimicrobial therapy. One patient had a solitary, white-yellow choroidal lesion in the left eye only. Choroidal lesions were hyperfluorescent on late-phase fluorescein angiography and corresponded to localized choroidal thickening and retinal elevation on SD-OCT. CONCLUSIONS: M. chimaera infection after cardiothoracic surgery can cause life-threatening disease involving multiple organ systems. Ocular involvement is an important and possibly early clinical finding, with good correlation to systemic disease severity. Ophthalmological assessment and multimodal imaging may aid in early diagnosis and can be used to monitor disease progression. CI - Copyright (c) 2021 Canadian Ophthalmological Society. Published by Elsevier Inc. All rights reserved. FAU - Ma, Jingyi AU - Ma J AD - Faculty of Medicine & Dentistry, University of Alberta, Edmonton, Alta. FAU - Ruzicki, Jessica L AU - Ruzicki JL AD - Department of Ophthalmology and Visual Sciences, University of Alberta, Edmonton, Alta. FAU - Carrell, Nathan W AU - Carrell NW AD - Department of Ophthalmology and Visual Sciences, University of Alberta, Edmonton, Alta. FAU - Baker, Chad F AU - Baker CF AD - Department of Ophthalmology and Visual Sciences, University of Alberta, Edmonton, Alta.. Electronic address: cfbaker@ualberta.ca. LA - eng PT - Journal Article DEP - 20210323 PL - England TA - Can J Ophthalmol JT - Canadian journal of ophthalmology. Journal canadien d'ophtalmologie JID - 0045312 RN - Mycobacterium chimaera SB - IM MH - Adult MH - Aged MH - Alberta MH - *Choroid/pathology MH - Humans MH - Middle Aged MH - *Mycobacterium MH - Retrospective Studies MH - Young Adult EDAT- 2021/03/30 06:00 MHDA- 2022/04/05 06:00 CRDT- 2021/03/29 05:50 PHST- 2021/01/18 00:00 [received] PHST- 2021/02/16 00:00 [revised] PHST- 2021/02/18 00:00 [accepted] PHST- 2021/03/30 06:00 [pubmed] PHST- 2022/04/05 06:00 [medline] PHST- 2021/03/29 05:50 [entrez] AID - S0008-4182(21)00081-8 [pii] AID - 10.1016/j.jcjo.2021.02.032 [doi] PST - ppublish SO - Can J Ophthalmol. 2022 Apr;57(2):90-97. doi: 10.1016/j.jcjo.2021.02.032. Epub 2021 Mar 23.